THE ANTI-CD20 ANTIBODY RITUXIMAB REDUCES THE INFLAMMATORY AND PROTHROMBOTIC PROFILE OF LEUKOCYTES FROM RHEUMATOID ARTHRITIS PATIENTS AND MODULATES THE ACTIVITY OF ENDOTHELIAL CELLS
No Thumbnail Available
Identifiers
Date
2017-06-01
Authors
Cecchi, I.
Perez-Sanchez, C.
Ruiz-Limon, P.
de la Rosa, I. Arias
Abalos-Aguilera, M. C.
Jimenez-Gomez, Y.
Ortega, R.
Collantes-Estevez, E.
Escudero, A.
Barbarroja, N.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Bmj publishing group
Metrics
Export
